WallStreetZenWallStreetZen

NASDAQ: TXMD
Therapeuticsmd Inc Stock Ownership - Who owns Therapeuticsmd?

Insider buying vs selling

Have Therapeuticsmd Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Marlan D. WalkerChief Executive Officer2023-12-074,550$2.24
$10.19kSell
Marlan D. WalkerChief Executive Officer2023-12-0614,500$2.31
$33.50kSell
Rubric Capital Management LPDirector2023-11-15877,192$2.28
$2.00MBuy
Rubric Capital Management LPDirector2023-06-28312,525$3.68
$1.15MBuy

1 of 1

TXMD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TXMD insiders and whales buy or sell their stock.

TXMD Shareholders

What type of owners hold Therapeuticsmd Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Brian Bernick266.15%30,693,311$62.92MInsider
Robert G. Finizio173.35%19,991,637$40.98MInsider
John Ck Milligan Iv88.72%10,231,927$20.98MInsider
Nicholas Segal42.21%4,868,382$9.98MInsider
Robin Natalie Tjon35.62%4,108,107$8.42MInsider
Kimberly Sarubbi35.62%4,108,107$8.42MInsider
Sky B. Kelley29.69%3,423,422$7.02MInsider
Rubric Capital Management LP25.55%2,946,908$6.04MInsider
Cooper C. Collins23.22%2,678,301$5.49MInsider
Tommy G. Thompson22.25%2,565,789$5.26MInsider

1 of 3

TXMD vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TXMD3.69%96.31%Net Buying
CPIX15.24%58.39%Net BuyingNet Selling
QLI0.11%0.00%
KALA1.24%98.76%Net SellingNet Selling
TLPH9.46%90.54%Net BuyingNet Buying

Therapeuticsmd Stock Ownership FAQ

Who owns Therapeuticsmd?

Therapeuticsmd (NASDAQ: TXMD) is owned by 29.28% institutional shareholders, 763.43% Therapeuticsmd insiders, and 0.00% retail investors. Brian Bernick is the largest individual Therapeuticsmd shareholder, owning 30.69M shares representing 266.15% of the company. Brian Bernick's Therapeuticsmd shares are currently valued at $60.77M.

If you're new to stock investing, here's how to buy Therapeuticsmd stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.